jump to content jump to footer

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule detection and segmentation, contextflow highlights findings directly within the mint Lesion platform, where users can seamlessly review, customize or add findings.

mint Lesion supports the Lung-RADS 2022 guidelines, featuring built-in automated scoring to enhance accuracy and consistency in lung nodule evaluation. contextflow ADVANCE Chest CT extends its capabilities beyond nodules, assisting in the analysis of COPD and *coming soon* identifying calcifications in coronary vessels, equipping users with deeper insights for comprehensive care.

Explore how the innovative solution is going to be integrated into the cutting-edge deepcOS® AIR® ecosystem. Check out this brief video on Youtube to see it in action.

English News Data Collection Standardized Reading Procedures Volumetric Measurements Diagnostic Data Management Data Analysis Interoperability AI Structured Reporting RADS

Related Resources

Radiologists working at workstations analyzing real CT images during an interactive RECIST workshop at ECR 2026
Insights into hands-on RECIST training at ECR 2026: interactive workshops, real cases, and structured reporting with mint Lesion
From Theory to Practice: Hands-On RECIST Training at ECR 2026
This year, Mint Medical contributed to multiple program highlights at the ECR 2026 - bringing together innovation, education, and real-world clinical…
Woman watching the Mint Medical and contextflow webinars on lung cancer screening in Germany on Youtube
Webinar series to explore different aspects of lung cancer screening in Germany
Webinar Series: Lung Cancer Screening in Germany - From Evidence to Implementation
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening…
From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials
The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…